Marksons Pharma voluntarily recalls a batch of Metformin XR tablets

It is due to the detection of NDMA as a matter of abundant precaution.

150
Recall
Picture: Pixabay

Marksans Pharma has issued a voluntary recall of one batch of Metformin Extended-Release Tablets USP 500 mg (11279 bottles, Lot No. XP9004), informed the company through a statement.

It is due to the detection of NDMA as a matter of abundant precaution.

Also read: India surplus in face mask production, allow exports: Industry

Metformin Extended-Release Tablets USP500 mg is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.